News and Events
We are pleased to announce that the European Commission's publication services published an article on ENSAT-HT and our work in their section "succes stories" last November.
Please find the original article here: Developing a blood test to diagnose curable hypertension
Read our latest related publication online:
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Nature Genetics volume 50, pages355–361 (2018)
Authors: Fabio L. Fernandes-Rosa, Georgios Daniil, Ian J. Orozco, Corinna Göppner, Rami El Zein, Vandana Jain, Sheerazed Boulkroun, Xavier Jeunemaitre, Laurence Amar, Hervé Lefebvre, Thomas Schwarzmayr, Tim M. Strom, Thomas J. Jentsch & Maria-Christina Zennaro
|
The annual ENSAT-HT consortium meeting took place from May 18th-19th May 2017 in Lisbon. The Agenda (copied below) included updates of the current status of work in all WPs as well as scientific talks, dicussions and working groups.
|
The annual ENSAT-HT consortium meeting will take place in Barcelona from 17th-18th May 2018.
The agenda will be composed of updates of the WPs and scientific talks.
The last ExCom meeting of ENSAT-HT took place on 24th November at the at University of Birmingham prior to the annual ENSAT network meeting.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633983
People
Scientific Coordinator: Dr Maria -Christina Zennaro, Head of INSERM U970 team 14: Genetic mechanisms of aldosterone-related disorders. maria-christina.zennaro@inserm.fr
Project Manager (INSERM-Transfert): Catherine Clusel catherine.clusel@inserm-transfert.fr
Project Manager (INSERM-Transfert): Kristina Fiedler kristina.fiedler@inserm-transfert.fr
More contact details here
Places
Paris Cardiovascular Research Center (PARCC), European Georges Pompidou Hospital, 56 rue Leblanc, 75015 Paris, France
INSERM-Transfert, Paris Biopark, 7 rue Watt, 75013 Paris, France